204 related articles for article (PubMed ID: 29081387)
1. Novel Toxoplasma gondii inhibitor chemotypes.
Sanford AG; Schulze TT; Potluri LP; Hemsley RM; Larson JJ; Judge AK; Zach SJ; Wang X; Charman SA; Vennerstrom JL; Davis PH
Parasitol Int; 2018 Apr; 67(2):107-111. PubMed ID: 29081387
[TBL] [Abstract][Full Text] [Related]
2. Derivatives of a benzoquinone acyl hydrazone with activity against Toxoplasma gondii.
Sanford AG; Schulze TT; Potluri LP; Watson GF; Darner EB; Zach SJ; Hemsley RM; Wallick AI; Warner RC; Charman SA; Wang X; Vennerstrom JL; Davis PH
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):488-492. PubMed ID: 30500526
[TBL] [Abstract][Full Text] [Related]
3. Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.
Murata Y; Sugi T; Weiss LM; Kato K
PLoS One; 2017; 12(6):e0178203. PubMed ID: 28609444
[TBL] [Abstract][Full Text] [Related]
4. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
[TBL] [Abstract][Full Text] [Related]
5. Identification of fungal natural products with potent inhibition in
Jiang T; Godinez-Macias KP; Collins JE; Lee JW; Wendt KL; Carolino K; Chakrabarti D; Cichewicz RH; Winzeler EA
Microbiol Spectr; 2024 Apr; 12(4):e0414223. PubMed ID: 38421191
[TBL] [Abstract][Full Text] [Related]
6. A protein extract and a cysteine protease inhibitor enriched fraction from Jatropha curcas seed cake have in vitro anti-Toxoplasma gondii activity.
Soares AM; Carvalho LP; Melo EJ; Costa HP; Vasconcelos IM; Oliveira JT
Exp Parasitol; 2015 Jun; 153():111-7. PubMed ID: 25816973
[TBL] [Abstract][Full Text] [Related]
7. Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.
Mui EJ; Schiehser GA; Milhous WK; Hsu H; Roberts CW; Kirisits M; Muench S; Rice D; Dubey JP; Fowble JW; Rathod PK; Queener SF; Liu SR; Jacobus DP; McLeod R
PLoS Negl Trop Dis; 2008 Mar; 2(3):e190. PubMed ID: 18320016
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of antiretroviral compounds against Toxoplasma gondii in vitro.
Wang JL; Elsheikha HM; Li TT; He JJ; Bai MJ; Liang QL; Zhu XQ; Cong W
Int J Antimicrob Agents; 2019 Dec; 54(6):814-819. PubMed ID: 31479744
[TBL] [Abstract][Full Text] [Related]
9. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
[TBL] [Abstract][Full Text] [Related]
10. Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening.
Deng Y; Wu T; Zhai SQ; Li CH
Eur J Med Chem; 2019 Dec; 183():111711. PubMed ID: 31585276
[TBL] [Abstract][Full Text] [Related]
11. Screening of a library of traditional Chinese medicines to identify compounds and extracts which inhibit Toxoplasma gondii growth.
Saito H; Murata Y; Nonaka M; Kato K
J Vet Med Sci; 2020 Feb; 82(2):184-187. PubMed ID: 31904004
[TBL] [Abstract][Full Text] [Related]
12. Sterculic Acid and Its Analogues Are Potent Inhibitors of Toxoplasma gondii.
Hao P; Alaraj IQ; Dulayymi JR; Baird MS; Liu J; Liu Q
Korean J Parasitol; 2016 Apr; 54(2):139-45. PubMed ID: 27180571
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
Rosowsky A; Papoulis AT; Forsch RA; Queener SF
J Med Chem; 1999 Mar; 42(6):1007-17. PubMed ID: 10090784
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Biological Evaluation of (+)-Usnic Acid Derivatives as Potential Anti-
Guo HY; Jin C; Zhang HM; Jin CM; Shen QK; Quan ZS
J Agric Food Chem; 2019 Aug; 67(34):9630-9642. PubMed ID: 31365255
[TBL] [Abstract][Full Text] [Related]
15. Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.
Spalenka J; Escotte-Binet S; Bakiri A; Hubert J; Renault JH; Velard F; Duchateau S; Aubert D; Huguenin A; Villena I
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133550
[No Abstract] [Full Text] [Related]
16. Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.
Stec J; Fomovska A; Afanador GA; Muench SP; Zhou Y; Lai BS; El Bissati K; Hickman MR; Lee PJ; Leed SE; Auschwitz JM; Sommervile C; Woods S; Roberts CW; Rice D; Prigge ST; McLeod R; Kozikowski AP
ChemMedChem; 2013 Jul; 8(7):1138-60. PubMed ID: 23776166
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential dual -targets anti- toxoplasma gondii compounds through structure-based virtual screening and in-vitro studies.
Salin NH; Noordin R; Al-Najjar BO; Kamarulzaman EE; Yunus MH; Karim IZA; Nasim NNM; Zakaria II; Wahab HA
PLoS One; 2020; 15(5):e0225232. PubMed ID: 32442170
[TBL] [Abstract][Full Text] [Related]
18. Screening of compound libraries for inhibitors of Toxoplasma growth and invasion.
Han Y; Adeyemi OS; Kabir MHB; Kato K
Parasitol Res; 2020 May; 119(5):1675-1681. PubMed ID: 32236711
[TBL] [Abstract][Full Text] [Related]
19. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.
Mui EJ; Jacobus D; Milhous WK; Schiehser G; Hsu H; Roberts CW; Kirisits MJ; McLeod R
Antimicrob Agents Chemother; 2005 Aug; 49(8):3463-7. PubMed ID: 16048961
[TBL] [Abstract][Full Text] [Related]
20. In vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductase.
Reynolds MG; Oh J; Roos DS
Antimicrob Agents Chemother; 2001 Apr; 45(4):1271-7. PubMed ID: 11257045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
